ciprofloxacin

Skin/Skin Structure Infections

PO (Adults ): 500–750 mg every 12 hr for 7–14 days.
IV (Adults ): 400 mg every 8–12 hr for 7–14 days.

Bone and Joint Infections

PO (Adults ): 500–750 mg every 12 hr for 4–8 wk.
IV (Adults ): 400 mg every 8–12 hr for 4–8 wk.

Complicated Intra-Abdominal Infections

PO (Adults ): 500 mg every 12 hr for 7–14 days.
IV (Adults ): 400 mg every 12 hr for 7–14 days.

Infectious Diarrhea

PO (Adults ): 500 mg every 12 hr for 5–7 days.

Typhoid Fever

PO (Adults ): 500 mg every 12 hr for 10 days.

Uncomplicated Urethral and Cervical Gonorrhea

PO (Adults ): 250 mg as a single dose.

Inhalational Anthrax (Postexposure)

PO (Adults ): 500 mg every 12 hr for 60 days.
PO (Children ): 15 mg/kg (max = 500 mg/dose) every 12 hr for 60 days.
IV (Adults ): 400 mg every 12 hr for 60 days.
IV (Children ): 10 mg/kg (max = 400 mg/dose) every 12 hr for 60 days.

Plague

PO (Adults ): 500–750 mg every 12 hr for 14 days.
PO (Children ): 15 mg/kg (max = 500 mg/dose) every 8–12 hr for 14 days.
IV (Adults ): 400 mg every 8–12 hr for 14 days.
IV (Children ): 10 mg/kg (max = 400 mg/dose) every 8–12 hr for 10–21 days.

Chronic Bacterial Prostatitis

PO (Adults ): 500 mg every 12 hr for 28 days.
IV (Adults ): 400 mg every 12 hr for 28 days.

Lower Respiratory Tract Infections

PO (Adults ): 500–750 mg every 12 hr for 7–14 days.
IV (Adults ): 400 mg every 8–12 hr for 7–14 days.

Nosocomial Pneumonia

IV (Adults ): 400 mg every 8 hr for 10–14 days.

Febrile Neutropenia

IV (Adults ): 400 mg every 8 hr for 7–14 days.

Urinary Tract Infections

PO (Adults ): Complicated UTI or acute pyelonephritis: 250–500 mg every 12 hr for 7–14 days; Acute uncomplicated cystitis: 250 mg every 12 hr for 3 days.
PO (Children 1–17 yr): Complicated UTI or pyelonephritis: 10–20 mg/kg (max = 750 mg/dose) every 12 hr for 10–21 days.
IV (Adults ): 200–400 mg every 8–12 hr for 7–14 days.
IV (Children 1–17 yr): Complicated UTI or pyelonephritis: 6–10 mg/kg (max = 400 mg/dose) every 8 hr for 10–21 days.

Acute Bacterial Sinusitis

PO (Adults ): 500 mg every 12 hr for 10 days.
IV (Adults ): 400 mg every 12 hr for 10 days.

Renal Impairment

PO (Adults ): CCr 30–50 mL/min: 250–500 mg every 12 hr; CCr 5–29 mL/min: 250–500 mg every 18 hr; Hemodialysis or peritoneal dialysis: 250–500 mg every 24 hr (give dose after dialysis session).

Renal Impairment

IV (Adults ): CCr 5–29 mL/min: 200–400 mg every 18–24 hr.

Availability ⬆ ⬇

(Generic available)

Immediate-release tablets: 250 mg; 500 mg; 750 mg
Oral suspension strawberry flavor: 250 mg/5 mL; 500 mg/5 mL
Premixed infusion: 200 mg/100 mL D5W; 400 mg/200 mL D5W
In combination with: fluocinolone (Otovel); hydrocortisone (Cipro HC) (see Appendix [not included in this PDA edition]).

Assessment ⬆ ⬇

Assess for signs and symptoms of particular infection at beginning of and throughout therapy.
Obtain specimens for culture and sensitivity before initiating therapy. First dose may be given before receiving results.
Observe for signs and symptoms of anaphylaxis (rash, pruritus, laryngeal edema, wheezing). Discontinue drug and provide appropriate medical care if symptoms occur. Keep epinephrine, antihistamine, and resuscitation equipment close by in case of an anaphylactic reaction.
Monitor bowel function. Diarrhea, abdominal cramping, fever, and bloody stools should be reported to health care provider promptly as a sign of CDAD. May begin up to several weeks following cessation of therapy.

Lab Test Considerations:

May ↑ serum AST, ALT, LDH, bilirubin, and alkaline phosphatase. Discontinue ciprofloxacin immediately if hepatitis occurs.
- May ↑ or ↓ serum glucose.

Implementation ⬆ ⬇

Assure adequate hydration prior to ciprofloxacin therapy to avoid crystalluria.
PO: Administer without regard to food and with a full glass of water, at the same time daily. Products or foods containing calcium, magnesium, aluminum, iron, or zinc should not be ingested for 6 hr before and 2 hr after administration.
- If GI irritation occurs, ciprofloxacin may be administered with meals. Food slows and may slightly ↓ absorption.
- Regular tablets can be crushed for patients unable to swallow.
- To prepare oral suspension, open both bottles provided. Pour microcapsules into larger bottle of diluent. Diluent volume varies by dose and concentration. For 250 mg dose, use 5 mL diluent for 250 mg/5 mL dose or 2.5 mL for 500 mg/5 mL dose. For 500 mg dose, use 10 mL diluent for 250 mg/5 mL dose or 5 mL for 500 mg/5 mL dose. For 750 mg dose, use 15 mL for 250 mg/5 mL dose or 7.5 mL diluent for 500 mg/5 mL dose. Do not add water to suspension. Solution is stable at room temperature for 14 days. Shake oral suspension vigorously for 15 sec before administering. Administer using the provided graduated teaspoon. Do not chew microcapsules in suspension; swallow whole. May follow with water.
- Do not administer oral suspension through an enteral feeding tube or with enteral feedings; may ↓ absorption.

IV Administration:

Intermittent Infusion: Diluent: Dilute vials with D5W, 0.9% NaCl or LR.Concentration: 1–2 mg/mL.Rate: Infuse over 60 min into a large vein to minimize venous irritation.
Y-Site Compatibility:
- alemtuzumab
- amifostine
- amiodarone
- anidulafungin
- argatroban
- arsenic trioxide
- aztreonam
- bivalirudin
- bleomycin
- caffeine citrate
- calcium gluconate
- carboplatin
- carmustine
- caspofungin
- ceftaroline
- ceftazidime
- ceftolozane/tazobactam
- cisatracurium
- cisplatin
- cyclophosphamide
- cytarabine
- dactinomycin
- daptomycin
- daunorubicin
- defibrotide
- dexmedetomidine
- dexrazoxane
- digoxin
- diltiazem
- dimenhydrinate
- diphenhydramine
- dobutamine
- docetaxel
- dopamine
- doxorubicin hydrochloride
- doxorubicin liposomal
- epirubicin
- eptifibatide
- eravacycline
- ertapenem
- etoposide
- etoposide phosphate
- fludarabine
- fosphenytoin
- gemcitabine
- gentamicin
- granisetron
- hetastarch
- hydromorphone
- idarubicin
- ifosfamide
- irinotecan
- isavuconazonium
- labetalol
- leucovorin
- lidocaine
- linezolid
- lorazepam
- meperidine
- mesna
- methadone
- methotrexate
- metoclopramide
- metoprolol
- metronidazole
- midazolam
- milrinone
- mitomycin
- mitoxantrone
- mycophenolate
- naloxone
- nicardipine
- octreotide
- ondansetron
- oritavancin
- oxaliplatin
- oxytocin
- paclitaxel
- palonosetron
- pamidronate
- plazomicin
- posaconazole
- potassium acetate
- potassium chloride
- promethazine
- remifentanil
- rifampin
- rocuronium
- sildenafil
- tacrolimus
- tedizolid
- telavancin
- thiotepa
- tigecycline
- tirofiban
- tobramycin
- topotecan
- trastuzumab
- vancomycin
- vasopressin
- vecuronium
- verapamil
- vinblastine
- vincristine
- vinorelbine
- voriconazole
- zoledronic acid
Y-Site Incompatibility:
- acyclovir
- aminocaproic acid
- aminophylline
- amphotericin B lipid complex
- amphotericin B liposomal
- ampicillin/sulbactam
- blinatumomab
- cangrelor
- cefepime
- dexamethasone
- esmolol
- fluorouracil
- foscarnet
- furosemide
- gemtuzumab ozogamicin
- heparin
- letermovir
- meropenem
- meropenem/vaborbactam
- methylprednisolone
- pantoprazole
- pemetrexed
- phenytoin
- piperacillin/tazobactam
- potassium phosphates
- propofol
- rituximab
- sodium phosphates
- sulbactam/durlobactam

Patient/Family Teaching ⬆ ⬇

Instruct patient to take medication as directed at evenly spaced times and to finish drug completely, even if feeling better. Take missed doses as soon as possible, unless within 6 hr of next dose. Do not double doses.
Advise patients to notify health care provider immediately if they are taking theophylline.
Encourage patient to maintain a fluid intake of ≥1500–2000 mL/day to prevent crystalluria.
Advise patient that antacids or medications containing calcium, magnesium, aluminum, iron, or zinc will ↓ absorption and should not be taken within 4 hr before and 2 hr after taking this medication.
May cause dizziness and drowsiness. Caution patient to avoid driving or other activities requiring alertness until response to medication is known.
Caution patient to use sunscreen and protective clothing to prevent phototoxicity reactions during and for 5 days after therapy. Notify health care provider if a sunburn-like reaction or skin eruption occurs.
Instruct patients being treated for gonorrhea that partners also must be treated.
Instruct patient to notify health care provider of all Rx or OTC medications, vitamins, or herbal products being taken and to consult health care provider before taking any other Rx, OTC, or herbal products.
Advise patient to report signs of superinfection (furry overgrowth on the tongue, vaginal itching or discharge, loose or foul-smelling stools).
Instruct patient to notify health care provider if fever and diarrhea develop, especially if stool contains blood, pus, or mucus. Advise patient not to treat diarrhea without consulting health care provider.
Instruct patient to notify health care provider immediately if signs and symptoms of hepatotoxicity (anorexia, jaundice, dark urine, pruritus, tender abdomen); rash; or signs of hypersensitivity occur.
Instruct patient to notify health care provider immediately if serious CNS effects (seizures, agitation, insomnia, anxiety, nightmares, paranoia, dizziness, confusion, tremors, hallucinations, depression, suicidal ideations/thoughts); peripheral neuropathy (pain, burning, tingling, numbness, weakness, other alterations in sensation); or tendon (shoulder, hand, Achilles, other) pain, swelling, or inflammation occur.
Inform patient that ciprofloxacin may cause worsening of myasthenia gravis symptoms (muscle weakness, breathing problems). Advise patient to notify health care provider immediately if symptoms occur.
Rep: Advise women of reproductive potential to notify health care provider if pregnancy is planned or suspected and to avoid breastfeeding during therapy and for 2 days after last dose unless being treated for inhalation anthrax.

Evaluation/Desired Outcomes ⬆ ⬇

Resolution of bacterial infection. Time for complete resolution depends on organism and site of infection.
Postexposure treatment of inhalational anthrax or cutaneous anthrax.

US Brand Names ⬆ ⬇

Code ⬆

NDC Code

0078- Novartis Pharmaceuticals Corporation
- 0078-0841- CILOXAN
  - 0078-0841-01- 3.5 g in 1 TUBE (0078-0841-01)

0143- Hikma Pharmaceuticals USA Inc.
- 0143-9927- Ciprofloxacin
  - 0143-9927-01- 100 TABLET, FILM COATED in 1 BOTTLE (0143-9927-01)

0143- Hikma Pharmaceuticals USA Inc.
- 0143-9927- Ciprofloxacin
  - 0143-9927-05- 500 TABLET, FILM COATED in 1 BOTTLE (0143-9927-05)

0143- Hikma Pharmaceuticals USA Inc.
- 0143-9927- Ciprofloxacin
  - 0143-9927-30- 30 TABLET, FILM COATED in 1 BOTTLE (0143-9927-30)

0143- Hikma Pharmaceuticals USA Inc.
- 0143-9928- Ciprofloxacin
  - 0143-9928-01- 100 TABLET, FILM COATED in 1 BOTTLE (0143-9928-01)

0143- Hikma Pharmaceuticals USA Inc.
- 0143-9928- Ciprofloxacin
  - 0143-9928-05- 500 TABLET, FILM COATED in 1 BOTTLE (0143-9928-05)

0143- Hikma Pharmaceuticals USA Inc.
- 0143-9928- Ciprofloxacin
  - 0143-9928-30- 30 TABLET, FILM COATED in 1 BOTTLE (0143-9928-30)

0143- Hikma Pharmaceuticals USA Inc.
- 0143-9929- Ciprofloxacin
  - 0143-9929-01- 100 TABLET, FILM COATED in 1 BOTTLE (0143-9929-01)

0143- Hikma Pharmaceuticals USA Inc.
- 0143-9929- Ciprofloxacin
  - 0143-9929-50- 50 TABLET, FILM COATED in 1 BOTTLE (0143-9929-50)

0409- Hospira, Inc.
- 0409-2300- Ciprofloxacin in Dextrose
  - 0409-2300-24- 24 POUCH in 1 CARTON (0409-2300-24) / 1 BAG in 1 POUCH (0409-2300-01) / 100 mL in 1 BAG

0409- Hospira, Inc.
- 0409-3300- Ciprofloxacin in Dextrose
  - 0409-3300-24- 24 POUCH in 1 CARTON (0409-3300-24) / 1 BAG in 1 POUCH (0409-3300-01) / 200 mL in 1 BAG

0615- NCS HealthCare of KY, LLC dba Vangard Labs
- 0615-8546- Ciprofloxacin
  - 0615-8546-10- 10 TABLET, FILM COATED in 1 BLISTER PACK (0615-8546-10)

0615- NCS HealthCare of KY, LLC dba Vangard Labs
- 0615-8546- Ciprofloxacin
  - 0615-8546-14- 14 TABLET, FILM COATED in 1 BLISTER PACK (0615-8546-14)

0615- NCS HealthCare of KY, LLC dba Vangard Labs
- 0615-8546- Ciprofloxacin
  - 0615-8546-20- 20 TABLET, FILM COATED in 1 BLISTER PACK (0615-8546-20)

0904- Major Pharmaceuticals
- 0904-7083- Ciprofloxacin
  - 0904-7083-61- 100 BLISTER PACK in 1 CARTON (0904-7083-61) / 1 TABLET, FILM COATED in 1 BLISTER PACK

0904- Major Pharmaceuticals
- 0904-7083- Ciprofloxacin
  - 0904-7083-95- 20 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0904-7083-95)

0904- Major Pharmaceuticals
- 0904-7243- ciprofloxacin
  - 0904-7243-61- 100 BLISTER PACK in 1 CARTON (0904-7243-61) / 1 TABLET, FILM COATED in 1 BLISTER PACK

0904- Major Pharmaceuticals
- 0904-7243- ciprofloxacin
  - 0904-7243-95- 20 TABLET, FILM COATED in 1 BOTTLE (0904-7243-95)

12527- Bayer AG
- 12527-0537-
  - 12527-0537-2- 50 kg in 1 DRUM (12527-0537-2)

12527- Bayer AG
- 12527-0540-
  - 12527-0540-1- 50 kg in 1 DRUM (12527-0540-1)

12527- Bayer AG
- 12527-8512-
  - 12527-8512-9- 83486 TABLET, FILM COATED in 1 CONTAINER (12527-8512-9)

12527- Bayer AG
- 12527-8513-
  12527-8513-9- 83486 TABLET, FILM COATED in 1 CONTAINER (12527-8513-9)

16252- Teva Pharmaceuticals USA, Inc.
- 16252-514-
  16252-514-00- 24630 TABLET, FILM COATED in 1 BOX (16252-514-00)

16252- Teva Pharmaceuticals USA, Inc.
- 16252-514- Ciprofloxacin
  16252-514-01- 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (16252-514-01)

16252- Teva Pharmaceuticals USA, Inc.
- 16252-515-
  - 16252-515-00- 12310 TABLET, FILM COATED in 1 BOX (16252-515-00)

16252- Teva Pharmaceuticals USA, Inc.
- 16252-515- Ciprofloxacin
  16252-515-01- 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (16252-515-01)

16252- Teva Pharmaceuticals USA, Inc.
- 16252-516-
  - 16252-516-00- 8216 TABLET, FILM COATED in 1 BOX (16252-516-00)

16252- Teva Pharmaceuticals USA, Inc.
- 16252-516- Ciprofloxacin
  16252-516-05- 50 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (16252-516-05)

16571- Rising Pharma Holdings, Inc.
- 16571-411- ciprofloxacin
  - 16571-411-10- 100 TABLET, FILM COATED in 1 BOTTLE (16571-411-10)

16571- Rising Pharma Holdings, Inc.
- 16571-412- ciprofloxacin
  - 16571-412-10- 100 TABLET, FILM COATED in 1 BOTTLE (16571-412-10)

16571- Rising Pharma Holdings, Inc.
- 16571-412- ciprofloxacin
  - 16571-412-50- 500 TABLET, FILM COATED in 1 BOTTLE (16571-412-50)

16571- Rising Pharma Holdings, Inc.
- 16571-413- ciprofloxacin
  - 16571-413-05- 50 TABLET, FILM COATED in 1 BOTTLE (16571-413-05)

23070- Bayer Healthcare Manufacturing Srl
- 23070-8513-
  - 23070-8513-9- 83486 TABLET in 1 CONTAINER (23070-8513-9)

25021- Sagent Pharmaceuticals
- 25021-114- Ciprofloxacin
  25021-114-82- 24 POUCH in 1 CARTON (25021-114-82) / 1 BAG in 1 POUCH / 100 mL in 1 BAG

25021- Sagent Pharmaceuticals
- 25021-114- Ciprofloxacin
  - 25021-114-87- 24 POUCH in 1 CARTON (25021-114-87) / 1 BAG in 1 POUCH / 200 mL in 1 BAG

25021- Sagent Pharmaceuticals
- 25021-192- Ciprofloxacin
  - 25021-192-82- 24 POUCH in 1 CARTON (25021-192-82) / 1 BAG in 1 POUCH / 100 mL in 1 BAG

25021- Sagent Pharmaceuticals
- 25021-192- Ciprofloxacin
  - 25021-192-87- 24 POUCH in 1 CARTON (25021-192-87) / 1 BAG in 1 POUCH / 200 mL in 1 BAG

38779- Medisca Inc.
- 38779-0534-
  - 38779-0534-5- 100 g in 1 JAR (38779-0534-5)

38779- Medisca Inc.
- 38779-0534-
  38779-0534-8- 500 g in 1 JAR (38779-0534-8)

38779- Medisca Inc.
- 38779-0534-
  38779-0534-9- 1000 g in 1 JAR (38779-0534-9)

42195- Xspire Pharma, Llc
- 42195-550- Ciprofloxacin Otic
  42195-550-14- 14 CONTAINER in 1 CARTON (42195-550-14) / .25 mL in 1 CONTAINER

42708- QPharma Inc
- 42708-002- Ciprofloxacin
  - 42708-002-14- 14 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (42708-002-14)

42708- QPharma Inc
- 42708-088- Ciprofloxacin
  - 42708-088-14- 14 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (42708-088-14)

42708- QPharma Inc
- 42708-146- Ciprofloxacin
  - 42708-146-14- 14 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (42708-146-14)

42708- QPharma, Inc.
- 42708-188- Ciprofloxacin
  - 42708-188-14- 14 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (42708-188-14)

43063- PD-Rx Pharmaceuticals, Inc.
- 43063-410- ciprofloxacin
  - 43063-410-06- 6 TABLET in 1 BOTTLE, PLASTIC (43063-410-06)

43063- PD-Rx Pharmaceuticals, Inc.
- 43063-410- ciprofloxacin
  - 43063-410-10- 10 TABLET in 1 BOTTLE, PLASTIC (43063-410-10)

43063- PD-Rx Pharmaceuticals, Inc.
- 43063-410- ciprofloxacin
  - 43063-410-12- 12 TABLET in 1 BOTTLE, PLASTIC (43063-410-12)

43063- PD-Rx Pharmaceuticals, Inc.
- 43063-410- ciprofloxacin
  - 43063-410-14- 14 TABLET in 1 BOTTLE, PLASTIC (43063-410-14)

43063- PD-Rx Pharmaceuticals, Inc.
- 43063-410- ciprofloxacin
  - 43063-410-20- 20 TABLET in 1 BOTTLE, PLASTIC (43063-410-20)

43063- PD-Rx Pharmaceuticals, Inc.
- 43063-547- Ciprofloxacin
  - 43063-547-01- 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-547-01)

43063- PD-Rx Pharmaceuticals, Inc.
- 43063-547- Ciprofloxacin
  - 43063-547-02- 2 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-547-02)

43063- PD-Rx Pharmaceuticals, Inc.
- 43063-547- Ciprofloxacin
  - 43063-547-03- 3 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-547-03)

43063- PD-Rx Pharmaceuticals, Inc.
- 43063-547- Ciprofloxacin
  - 43063-547-04- 4 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-547-04)

43063- PD-Rx Pharmaceuticals, Inc.
- 43063-547- Ciprofloxacin
  - 43063-547-06- 6 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-547-06)

43063- PD-Rx Pharmaceuticals, Inc.
- 43063-547- Ciprofloxacin
  - 43063-547-10- 10 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-547-10)

43063- PD-Rx Pharmaceuticals, Inc.
- 43063-547- Ciprofloxacin
  - 43063-547-14- 14 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-547-14)

43063- PD-Rx Pharmaceuticals, Inc.
- 43063-547- Ciprofloxacin
  - 43063-547-20- 20 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-547-20)

43063- PD-Rx Pharmaceuticals, Inc.
- 43063-547- Ciprofloxacin
  - 43063-547-28- 28 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-547-28)

43063- PD-Rx Pharmaceuticals, Inc.
- 43063-547- Ciprofloxacin
  - 43063-547-30- 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-547-30)

43063- PD-Rx Pharmaceuticals, Inc.
- 43063-547- Ciprofloxacin
  - 43063-547-79- 1 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-547-79)

43063- PD-Rx Pharmaceuticals, Inc.
- 43063-547- Ciprofloxacin
  - 43063-547-82- 500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-547-82)

43063- PD-Rx Pharmaceuticals, Inc.
- 43063-767- ciprofloxacin
  - 43063-767-28- 28 TABLET in 1 BOTTLE, PLASTIC (43063-767-28)

43063- PD-Rx Pharmaceuticals, Inc.
- 43063-869- ciprofloxacin
  - 43063-869-06- 6 TABLET in 1 BOTTLE, PLASTIC (43063-869-06)

43063- PD-Rx Pharmaceuticals, Inc.
- 43063-869- ciprofloxacin
  - 43063-869-08- 8 TABLET in 1 BOTTLE, PLASTIC (43063-869-08)

43063- PD-Rx Pharmaceuticals, Inc.
- 43063-869- ciprofloxacin
  - 43063-869-10- 10 TABLET in 1 BOTTLE, PLASTIC (43063-869-10)

43063- PD-Rx Pharmaceuticals, Inc.
- 43063-869- ciprofloxacin
  - 43063-869-20- 20 TABLET in 1 BOTTLE, PLASTIC (43063-869-20)

43063- PD-Rx Pharmaceuticals, Inc.
- 43063-869- ciprofloxacin
  - 43063-869-30- 30 TABLET in 1 BOTTLE, PLASTIC (43063-869-30)

43063- PD-Rx Pharmaceuticals, Inc.
- 43063-923- Ciprofloxacin
  - 43063-923-02- 2 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-923-02)

43063- PD-Rx Pharmaceuticals, Inc.
- 43063-923- Ciprofloxacin
  - 43063-923-04- 4 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-923-04)

43063- PD-Rx Pharmaceuticals, Inc.
- 43063-923- Ciprofloxacin
  - 43063-923-06- 6 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-923-06)

43063- PD-Rx Pharmaceuticals, Inc.
- 43063-923- Ciprofloxacin
  - 43063-923-10- 10 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-923-10)

43063- PD-Rx Pharmaceuticals, Inc.
- 43063-923- Ciprofloxacin
  - 43063-923-14- 14 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-923-14)

43063- PD-Rx Pharmaceuticals, Inc.
- 43063-923- Ciprofloxacin
  - 43063-923-20- 20 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-923-20)

43063- PD-Rx Pharmaceuticals, Inc.
- 43063-923- Ciprofloxacin
  - 43063-923-28- 28 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-923-28)

43063- PD-Rx Pharmaceuticals, Inc.
- 43063-923- Ciprofloxacin
  - 43063-923-30- 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-923-30)

45865- Medsource Pharmaceuticals
- 45865-171- Ciprofloxacin
  - 45865-171-28- 28 TABLET, FILM COATED in 1 BOTTLE (45865-171-28)

50090- A-S Medication Solutions
- 50090-0882- Ciprofloxacin Hydrochloride
  - 50090-0882-0- 1 BOTTLE, PLASTIC in 1 CARTON (50090-0882-0) / 5 mL in 1 BOTTLE, PLASTIC

50090- A-S Medication Solutions
- 50090-1648- ciprofloxacin
  - 50090-1648-0- 20 TABLET in 1 BOTTLE (50090-1648-0)

50090- A-S Medication Solutions
- 50090-1648- ciprofloxacin
  - 50090-1648-1- 14 TABLET in 1 BOTTLE (50090-1648-1)

50090- A-S Medication Solutions
- 50090-1648- ciprofloxacin
  - 50090-1648-3- 6 TABLET in 1 BOTTLE (50090-1648-3)

50090- A-S Medication Solutions
- 50090-1648- ciprofloxacin
  - 50090-1648-4- 28 TABLET in 1 BOTTLE (50090-1648-4)

50090- A-S Medication Solutions
- 50090-1648- ciprofloxacin
  - 50090-1648-5- 10 TABLET in 1 BOTTLE (50090-1648-5)

50090- A-S Medication Solutions
- 50090-1648- ciprofloxacin
  - 50090-1648-7- 30 TABLET in 1 BOTTLE (50090-1648-7)

50090- A-S Medication Solutions
- 50090-1648- ciprofloxacin
  - 50090-1648-8- 1 TABLET in 1 BOTTLE (50090-1648-8)

50090- A-S Medication Solutions
- 50090-1649- ciprofloxacin
  - 50090-1649-0- 20 TABLET in 1 BOTTLE (50090-1649-0)

50090- A-S Medication Solutions
- 50090-1649- ciprofloxacin
  - 50090-1649-1- 14 TABLET in 1 BOTTLE (50090-1649-1)

50090- A-S Medication Solutions
- 50090-1754- Ciprofloxacin Hydrochloride
  - 50090-1754-0- 1 BOTTLE, PLASTIC in 1 CARTON (50090-1754-0) / 2.5 mL in 1 BOTTLE, PLASTIC

50090- A-S Medication Solutions
- 50090-2146- Ciprofloxacin
  - 50090-2146-0- 6 TABLET, FILM COATED in 1 BOTTLE (50090-2146-0)

50090- A-S Medication Solutions
- 50090-2146- Ciprofloxacin
  - 50090-2146-1- 14 TABLET, FILM COATED in 1 BOTTLE (50090-2146-1)

50090- A-S Medication Solutions
- 50090-2146- Ciprofloxacin
  - 50090-2146-2- 10 TABLET, FILM COATED in 1 BOTTLE (50090-2146-2)

50090- A-S Medication Solutions
- 50090-2146- Ciprofloxacin
  - 50090-2146-3- 3 TABLET, FILM COATED in 1 BOTTLE (50090-2146-3)

50090- A-S Medication Solutions
- 50090-3791- Ciprofloxacin
  - 50090-3791-0- 20 TABLET, FILM COATED in 1 BOTTLE (50090-3791-0)

50090- A-S Medication Solutions
- 50090-3791- Ciprofloxacin
  - 50090-3791-1- 14 TABLET, FILM COATED in 1 BOTTLE (50090-3791-1)

50090- A-S Medication Solutions
- 50090-3791- Ciprofloxacin
  - 50090-3791-3- 6 TABLET, FILM COATED in 1 BOTTLE (50090-3791-3)

50090- A-S Medication Solutions
- 50090-3791- Ciprofloxacin
  - 50090-3791-4- 28 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50090-3791-4)

50090- A-S Medication Solutions
- 50090-3791- Ciprofloxacin
  - 50090-3791-5- 10 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50090-3791-5)

50090- A-S Medication Solutions
- 50090-3791- Ciprofloxacin
  - 50090-3791-7- 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50090-3791-7)

50090- A-S Medication Solutions
- 50090-3791- Ciprofloxacin
  - 50090-3791-8- 1 TABLET, FILM COATED in 1 BOTTLE (50090-3791-8)

50090- A-S Medication Solutions
- 50090-3852- Ciprofloxacin
  - 50090-3852-0- 20 TABLET, FILM COATED in 1 BOTTLE (50090-3852-0)

50090- A-S Medication Solutions
- 50090-4217- ciprofloxacin
  - 50090-4217-0- 1 BOTTLE, PLASTIC in 1 CARTON (50090-4217-0) / 5 mL in 1 BOTTLE, PLASTIC

ROUTE	ONSET	PEAK	DURATION
PO	rapid	1–2 hr	12 hr
IV	rapid	end of infusion	12 hr

section name header

Pronunciation ⬇

Classifications ⬆ ⬇

Indications ⬆ ⬇

Action ⬆ ⬇

Pharmacokinetics ⬆ ⬇

Time/Action Profile ⬆ ⬇

Contraind./Precautions ⬆ ⬇

Adv. Reactions/Side Effects ⬆ ⬇

Interactions ⬆ ⬇